Buff Gold Ventures is a venture capital firm that invests in early-stage startups affiliated with the University of Colorado Boulder, including alumni, faculty, students, and companies licensing CU intellectual property, to create transformative and impactful companies.
33% of their portfolio is in Biotech & Life Sciences. They made 1 investment in the last 12 months. Their most common stage is seed (50% of deals). Average disclosed round size is $23.8M (across 4 rounds with reported amounts).
Portfolio
5
Fund Size
$25M
Top Stage
Seed
Last 12 Mo
1
Team
SH
Sally Hatcher
Co-Founder and Managing Partner
MT
Mark T. Lupa
Managing Director
TV
Tasso von Windheim
Associate
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
6 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Think Bioscience | Series A | $55M | Jan 2026 |
 SinusLogic | Seed | — | Jan 2023 |
 LongPath Technologies | Series A | $22M | Dec 2022 |
| Think Bioscience | Seed | $17M | Aug 2022 |
| VVitro3D | Seed | $1.3M | Jan 2022 |
 Polaris Electro-Optics | Pre-Seed | — | — |
Top Co-Investors
Innovation Endeavors2 shared
AV8 Ventures2 shared
System.One1 shared
ConocoPhillips1 shared
YK Bioventures1 shared
Crescent Enterprises1 shared
ReGen Ventures1 shared
T.A. Springer1 shared
CE Ventures1 shared
CU Innovations1 shared
Headline1 shared
MBX Capital1 shared
Xora1 shared
Rhapsody Venture Partners1 shared
M Ventures1 shared
Avila VC1 shared
private angel investors1 shared
Last updated: 7 October 2026